The global fight against antimicrobial resistance (AMR) is facing a critical challenge: more and more expert antimicrobial researchers are leaving the field or retiring. As the number of researchers in the field declines (see here), our ability to develop new antibiotics and treatments is at risk. This webinar explored the current state of the antimicrobial R&D expertise, the causes behind the shortage of specialized researchers, and innovative solutions to reverse the trend. Industry leaders, policy experts, and emerging researchers discussed strategies to attract and retain talent in antimicrobial research. Topics included the role of academia, the impact of economic incentives, and policy interventions such as global funding and support mechanisms. Watch the recording for a dynamic discussion on how we can work together to rebuild a sustainable, diverse antimicrobial research community and secure the future of antimicrobial development.
Speakers:
- Heike Brötz-Oesterhelt, Professor of Microbiology, Dept. of Microbial Bioactive Compounds, University of Tübingen (Germany)
- Marc Lemonnier, CEO of Antabio SAS (France)
- Alexandra Cameron, Senior Technical Officer at WHO (Switzerland)
- Jonathan Stokes, Assistant Professor at the Department of Biochemistry and Biomedical Sciences at McMaster University (Canada)
Moderator:
- Lesley Ogilvie, Secretariat Director at the Global AMR R&D Hub (Germany)
This webinar was done in collaboration with the European Partnership on One Health Antimicrobial Resistance OHAMR.
This webinar including an interactive Q&A session was broadcast on 3 September 2026.
If you have questions or comments, please let us know: revive@gardp.org.